My law practice is now mostly focused on pharmaceutical and health law. I discovered my interest in these fields during my studies at university, when I first started working in the pharmaceutical industry, and it hasn't left me even today. I gained experience in these areas not only in the legal profession, where I focused on corporate law and tax, but also in the association of pharmaceutical companies and during my internship at the Council of the European Union in Brussels, where I worked for the Public Health and Foodstuffs Department.
vladka.lastuvkova@havelpartners.czContributed to articles
Amendment to the Act on Medicinal Products; new obligations to ensure availability of medicinal products
An amendment to the Act on Medicinal Products entered into effect as of 1 January 2024, imposing numerous new obligations on marketing authorisation holders, distributors and pharmacies, and expanding the existing powers of administrative authorities. The changes are primarily aimed at ensuring the
Czech government approved new obligations to ensure availability of medicines – is the market ready?
Marketing authorisation holders, distributors and pharmacies may be facing new obligations to ensure the availability of medicinal products on the Czech market. In fact, on 14 June 2023, the Government approved an amendment to the Medicines Act. The proposal will now be debated in the Chamber of Dep